Skin Structure and Blister Formation

The human skin consists of multiple layers, with the epidermis forming the outermost layer. Keratinocytes, the primary cells in the epidermis, are held together by specialized connecting structures that provide mechanical stability. When these structures are compromised, blisters can form on the skin or mucous membranes.

Etiology

Blisters can arise from various causes, including:

• Autoimmune Diseases: In conditions like pemphigus vulgaris and bullous pemphigoid, the immune system attacks the body’s own connecting structures in the skin, leading to blister formation.
• Physical Factors:
  • Friction: Repetitive rubbing can cause blisters, especially on hands and feet.
  • Temperature extremes: Both burns and frostbite can result in blistering.
• Infections:
  • Viral: Chickenpox, herpes simplex virus
  • Bacterial: Bullous impetigo, staphylococcal scalded skin syndrome (SSSS)
• Allergic Reactions: Contact with certain chemicals, cosmetics, or plant allergens can trigger blistering.
• Medications: Some drugs can cause blistering as a side effect.
• Genetic Conditions: Rare inherited disorders like epidermolysis bullosa can cause skin fragility and blistering.

Pathophysiology

In autoimmune blistering diseases, the pathophysiology involves:

1. Autoantibody production against skin antigens.
2. Binding of autoantibodies to target structures (e.g., hemidesmosomes in bullous pemphigoid).
3. Complement system activation.
4. Enzymatic degradation of connecting structures.
5. Blister formation.

Recent studies have shown that in bullous pemphigoid, IgG4 autoantibodies may contribute to blister formation independently of complement activation.

Diagnosis

• Medical History: Often indicative of the underlying condition.
• Physical Examination: Blisters may be localized or disseminated depending on the cause.
• Histology: Skin biopsy for microscopic examination.
• Immunofluorescence: To detect autoantibody deposits in autoimmune blistering diseases.
• Serology: To identify specific autoantibodies.

Treatment

Treatment approaches vary based on the underlying cause:

• Autoimmune Blistering Diseases:
  • Systemic corticosteroids remain the standard treatment.
  • Rituximab (anti-CD20 antibody) has shown efficacy in pemphigus and pemphigoid.
  • Intravenous immunoglobulin (IVIG) for severe cases.
  • Doxycycline has shown promise as a safer alternative to prednisolone in bullous pemphigoid.
• Friction Blisters:
  • Generally heal on their own in 1-2 weeks.
  • Protect with bandages and padding.
• Infection-Related Blisters:
  • Antiviral medications for herpes simplex and shingles.
  • Antibiotics for impetigo.
• Allergic Contact Dermatitis:
  • Avoid the allergen.
  • Topical or systemic corticosteroids may be prescribed.